The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

For only three of Michigan's nine confirmed measles cases, public announcements came quickly enough for people to get post-exposure treatment.

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases ...

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

Overall, complaints are relatively rare compared to positive reviews, and the company offers a 180-day money-back guarantee ...

Leading the Business Post website is an article by Fionn Thompson that mortgage drawdowns increased 19 per cent to €2.8bn in ...

Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food. CTx-1301 is Designed as a True, Entire Active-Day Treatment for ADHD. KANSAS CITY, Kan., April 29, 2025 ( ...

Researchers at the University of Virginia say they successfully desensitized children to peanut allergies using "Early Peanut ...

At Children’s Hospital of Philadelphia, an 11-year-old girl with severe beta thalassamia, became the first pediatric patient to receive Zyntelgo, the first FDA-approved gene therapy for ...

ProDentim is rated 5 stars by over 95,000 satisfied customers. It combines 3.5 billion CFUs of powerful probiotics, including ...